Larvol Delta - Plasma-and-urinary-NMR-metabolic-profiling-of-the-phenylalaninetyrosine-pathway-in-nitisinonetreated-alkaptonuria-comparison-of-two-dosing-regimens-and-identification-of-a-candidate-pharmacodynamic-biomarker

Dificid (fidaxomicin) - Merck (MSD), Astellas

http://www.ncbi.nlm.nih.gov/pubmed/42692355

; Elena Rubio-Martín; Javier Cobo; Rosa Escudero-Sanchez

Sep 4, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next